Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Harvard Bioscience (HBIO) Enterprise Value (2016 - 2025)

Historic Enterprise Value for Harvard Bioscience (HBIO) over the last 17 years, with Q3 2025 value amounting to -$6.8 million.

  • Harvard Bioscience's Enterprise Value fell 4920.11% to -$6.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.8 million, marking a year-over-year decrease of 4920.11%. This contributed to the annual value of -$4.1 million for FY2024, which is 408.59% up from last year.
  • Harvard Bioscience's Enterprise Value amounted to -$6.8 million in Q3 2025, which was down 4920.11% from -$7.4 million recorded in Q2 2025.
  • Harvard Bioscience's 5-year Enterprise Value high stood at -$3.8 million for Q1 2023, and its period low was -$7.8 million during Q4 2021.
  • Moreover, its 5-year median value for Enterprise Value was -$5.1 million (2022), whereas its average is -$5.2 million.
  • Per our database at Business Quant, Harvard Bioscience's Enterprise Value plummeted by 13723.85% in 2021 and then soared by 4236.03% in 2022.
  • Over the past 5 years, Harvard Bioscience's Enterprise Value (Quarter) stood at -$7.8 million in 2021, then surged by 42.36% to -$4.5 million in 2022, then rose by 4.99% to -$4.3 million in 2023, then rose by 4.09% to -$4.1 million in 2024, then crashed by 65.94% to -$6.8 million in 2025.
  • Its last three reported values are -$6.8 million in Q3 2025, -$7.4 million for Q2 2025, and -$5.5 million during Q1 2025.